Bank of Montreal Can Sells 128,166 Shares of ResMed Inc.

The firm owned 203,480 shares of the medical equipment provider's stock after selling 128,166 shares during the period.

Mar. 13, 2026 at 7:27am

Got story updates? Submit your updates here. ›

Bank of Montreal Can cut its holdings in shares of ResMed Inc. (NYSE:RMD) by 38.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 203,480 shares of the medical equipment provider's stock after selling 128,166 shares during the period.

Why it matters

This transaction by Bank of Montreal Can reflects changes in its investment strategy and portfolio allocation for ResMed, a leading medical device company focused on sleep-disordered breathing and chronic respiratory conditions. The sale of a significant portion of its ResMed holdings may signal a shift in the bank's outlook on the company or the broader medical equipment sector.

The details

According to the 13F filing, Bank of Montreal Can owned 0.14% of ResMed worth $55,699,000 as of the end of the 3rd quarter. The firm sold 128,166 shares of ResMed during the period, reducing its total holdings by 38.6%.

  • Bank of Montreal Can filed the 13F report disclosing the ResMed share sale in the 3rd quarter of 2026.

The players

Bank of Montreal Can

A major Canadian financial institution and investment management firm.

ResMed Inc.

An American medical device company that develops, manufactures, and distributes products for the treatment of sleep-disordered breathing and other respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The sale of a significant portion of its ResMed holdings by Bank of Montreal Can suggests a potential shift in the firm's investment strategy or outlook on the medical equipment sector. Investors and analysts will likely monitor any further changes to Bank of Montreal Can's ResMed position in future regulatory filings.